Annotated Medicine and Device Lists


Efavirenz (EFV or EFZ)

This medicine is present in:

List Section Observation
PAHO Strategic Fund Medicine List 2.5. Antiretrovirals No observations
Peru 6.4.2.2 Non-Nucleoside Reverse Transcriptase Inhibitors No observations
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. Anti-Retroviral Treatment Programme No observations
Bolivia. Lista Nacional de Medicamentos Esenciales 2018-2020 05 ANTIVIRALES DE USO SISTÉMICO No observations
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 07.07 ANTIVIRALS No observations
Mexico. Cuadro Basico de Medicamentos - 2017 06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS No observations
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 J. ANTI-INFECCIOSOS PARA USO SISTEMICO No observations
El Salvador - 2019 ANTIVIRALES DE USO SISTÉMICO No observations

This medicine is present in:

This medicine is present in:

List Section Observation
Ecuador Essential Medicines List - Ecuador No observations

This medicine is present in:

List Section Observation
PAHO Strategic Fund Medicine List 2.5. Antiretrovirals Others observations:
Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times.
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 07.07 ANTIVIRALS No observations

This medicine is present in:

List Section Observation
Colombia. "Listado de Medicamentos del Plan de Beneficios en Salud con Cargo a la UPC" 2016 Listado de Medicamentos del Plan de Beneficios en Salud con cargo a la UPC Others observations:
INCLUYE TODAS LAS CONCENTRACIONES Y FORMAS FARMACÉUTICAS
Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 03.04. ANTIVIRALES No observations

This medicine is present in:

List Section Observation
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 07.07 ANTIVIRALS No observations
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 J. ANTI-INFECCIOSOS PARA USO SISTEMICO No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines 2019 6.4.2.2. Non-nucleoside reverse transcriptase inhibitors Age or weight restriction: >3 years or >10 kg weight.
PAHO Strategic Fund Medicine List 2.5. Antiretrovirals No observations
Peru 6.4.2.2 Non-Nucleoside Reverse Transcriptase Inhibitors No observations
Bolivia. Lista Nacional de Medicamentos Esenciales 2018-2020 05 ANTIVIRALES DE USO SISTÉMICO No observations
Mexico. Cuadro Basico de Medicamentos - 2017 06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS No observations
Costa Rica. Caja Costarricense de Seguro Social. 2019 04. Antifungicos y Antivirales No observations
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 J. ANTI-INFECCIOSOS PARA USO SISTEMICO No observations
Paraguay. Lista de Medicamentos Esenciales. 2009 05. ANTIVIRALES DE USO SISTÉMICO No observations
El Salvador - 2019 ANTIVIRALES DE USO SISTÉMICO No observations
El Salvador - 2019 ANTIVIRALES DE USO SISTÉMICO No observations
Chile. Formulario Nacional de Medicamentos. 2005 06.05. ANTIVIRALES No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines 2019 6.4.2.2. Non-nucleoside reverse transcriptase inhibitors Age or weight restriction: >3 years or >10 kg weight
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. Others observations:
FCO X 90 TABLETAS
Chile. Formulario Nacional de Medicamentos. 2005 06.05. ANTIVIRALES No observations

This medicine is present in:

List Section Observation
Chile. Formulario Nacional de Medicamentos. 2005 06.05. ANTIVIRALES No observations

This medicine is present in:

List Section Observation
Chile. Formulario Nacional de Medicamentos. 2005 06.05. ANTIVIRALES No observations

Information Resources: Efavirenz (EFV or EFZ)

Loading ...
Loading ...
Loading ...
No information available